October 25, 2017

European approvals face delay from agency move

How the EMA's move out of London could impact European drug approvals.

October 02, 2017

Ablynx sees payoff from Hercules labours

August 07, 2017

Interview – Santhera readies muscular dystrophy push

April 28, 2017

Snippets roundup: Sanofi diabetes disappointment, and Amgen pullback signals CGRP caution

April 19, 2017

Ultragenyx bounces back, but painful questions remain

January 13, 2017

Upcoming events – Life beyond sola and Ampyra for Lilly and Acorda

January 11, 2017

JP Morgan day two roundup – all talk, very little action

December 23, 2016

Snippet roundup: Biogen's chief exec choice underwhelms as a big 2016 decision is delayed to 2017

November 23, 2016

Novo and Sanofi cut thinner slice of the diabetes pie